Ovarian Hyperstimulation Syndrome
Showing 1 - 25 of >10,000
Ovarian Hyperstimulation Syndrome Trial in Banha (dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7
Suspended
- Ovarian Hyperstimulation Syndrome
- dydrgesterone 10 mg( tab)/12hs/14 days
- montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days
-
Banha, Qalyubiya, EgyptBanha University- Hawaa Fertility center
Sep 18, 2022
Ovarian Hyperstimulation Syndrome Trial (Calcium intravenous infsuion, 0.9 % saline)
Not yet recruiting
- Ovarian Hyperstimulation Syndrome
- Calcium intravenous infsuion
- 0.9 % saline
- (no location specified)
Feb 20, 2022
Live Birth Rate and Serum Progesterone During Hormonal
Completed
- Ovarian Hyperstimulation Syndrome
- Frozen-thawed Embryo Transfers
- Identification of predictive factors
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Oct 17, 2022
Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early
Not yet recruiting
- Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation
- SHR7280;Ganirelix Acetate Injection simulant
- SHR7280 simulant; Ganirelix Acetate Injection
- (no location specified)
Aug 15, 2023
Ovarian Hyperstimulation Syndrome, Infertility, Female Trial in Toronto (Pregnyl (1,500) IU, 1.5 mL of normal saline)
Recruiting
- Ovarian Hyperstimulation Syndrome
- Infertility, Female
- Pregnyl (1,500) IU
- 1.5 mL of normal saline
-
Toronto, Ontario, CanadaMount Sinai Hospital, Fertility Clinic
Dec 9, 2022
Freeze All Strategy Versus Fresh Embryo Transfer After GnRH
Completed
- Ovarian Hyperstimulation Syndrome
- Pregnancy Related
- obstetric outcomes after fresh versus cryopreserved embryo transfer
- (no location specified)
May 11, 2022
Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation Trial in China (BG2109, Cetrorelix)
Not yet recruiting
- Assisted Reproductive Technology
- Controlled Ovarian Hyperstimulation
-
Changsha, China
- +9 more
Feb 21, 2023
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome Trial in Tehran (Minimal ovarian stimulation)
Completed
- Polycystic Ovary Syndrome
- Ovarian Hyperstimulation Syndrome
- Minimal ovarian stimulation
-
Tehran, Iran, Islamic Republic ofRoyan Institute
Apr 18, 2021
Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome Trial in Be'er Ya'aqov (Synarel, 0.2 Mg/Inh Nasal Spray,
Recruiting
- Pregnancy Early
- +2 more
- Synarel, 0.2 Mg/Inh Nasal Spray
- +3 more
-
Be'er Ya'aqov, IsraelShamir Medical center
Mar 27, 2021
Polycystic Ovarian Syndrome (PCOS), Patients Sensitive to Exogenous Gonadotropins, Ovarian Hyper Stimulation Syndrome (OHSS)
Withdrawn
- Polycystic Ovarian Syndrome (PCOS)
- +2 more
- In Vitro maturation
-
Manhasset, New YorkThe Center for Human Reproduction
Nov 12, 2020
Ovarian Hyperstimulation Syndrome Trial in Potenza (recombinant LH)
Completed
- Ovarian Hyperstimulation Syndrome
- recombinant LH
-
Potenza, Basilicata, Italy
- +1 more
Nov 22, 2020
Ovarian Hyperstimulation Syndrome Trial in Cairo (Fludrocortisone 0.1 Milligrams (mg), Bromocriptine)
Completed
- Ovarian Hyperstimulation Syndrome
- Fludrocortisone 0.1 Milligrams (mg)
- Bromocriptine
-
Cairo, Maadi, EgyptGanin Fertility Center
Apr 16, 2020
Medical Assistance for the Procreation and Risk of Thrombosis.
Terminated
- Ovarian Hyperstimulation Syndrome
- +2 more
- ovarian stimulation
-
Brest, France
- +8 more
Jul 8, 2020
Serum Anti-Müllerian Hormone (AMH) Measurements
Recruiting
- Anti-Müllerian Hormone
- +3 more
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
May 12, 2023
Female Subjects Undergoing COH in ART to Prevent Early Ovulation Trial in Beijing (SHR7280 tablets)
Active, not recruiting
- Female Subjects Undergoing COH in ART to Prevent Early Ovulation
- SHR7280 tablets
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 11, 2022
Ovarian Hyperstimulation Syndrome, Hypercoagulability Trial (COAGO)
Terminated
- Ovarian Hyperstimulation Syndrome
- Hypercoagulability
- COAGO
- (no location specified)
Oct 1, 2019
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome Trial (GnRH antagonist, MPA)
Not yet recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- MPA
- (no location specified)
Apr 9, 2022
Infertility,Female Trial in Changsha (Growth hormone)
Recruiting
- Infertility,Female
- Growth hormone
-
Changsha, Hunan, ChinaReproductive & Genetic Hospital of CITIC-XIANGYA
Jan 10, 2022
Ovarian Hyperstimulation Syndrome Trial in Cairo (Gonadotropin, Antagonist)
Completed
- Ovarian Hyperstimulation Syndrome
-
Cairo, Egypt
- +1 more
Nov 20, 2019
Infertility, Ovarian Dysfunction Trial in Budapest (Follitropin Alfa, Follitropin delta, human menopausal gonadotropin)
Recruiting
- Infertility
- Ovarian Dysfunction
- Follitropin Alfa
- +2 more
-
Budapest, HungaryDunamenti REK Reprodukciós Központ
May 3, 2022
Patients With Polycystic Ovary Syndrome (PCOS)
Recruiting
- Polycystic Ovary Syndrome
- Ovary Biopsie
-
Tirana, AlbaniaUniversity of medicine of Tirana
Jul 28, 2023
Endometriosis, Ovarian Hyperstimulation Trial in San Francisco (Placebo oral tablet, Letrozole)
Recruiting
- Endometriosis
- Ovarian Hyperstimulation
- Placebo oral tablet
- Letrozole
-
San Francisco, CaliforniaUCSF Center for Reproductive Health
Sep 28, 2021
Polycystic Ovary Syndrome Trial in Bani Suwayf (Sitagliptin 100mg)
Not yet recruiting
- Polycystic Ovary Syndrome
- Sitagliptin 100mg
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Insulin Resistance With Hormonal and Ovarian Morphological
Not yet recruiting
- Study the Relationship Between Insulin Resistance With Hormonal and Ovarian Morphological Characteristics in Patients With Polycystic Ovarian Syndrome
- No intervention
- (no location specified)
Dec 14, 2022
Infertility, In Vitro Fertilization Trial (Org 36286, Puregon®, Orgalutran®)
Completed
- Infertility
- In Vitro Fertilization
- Org 36286
- +3 more
- (no location specified)
Feb 1, 2022